XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,675,312) $ (3,856,693)
Adjustments to reconcile net loss to net cash used in operating activities:    
Research and development-acquired patent, expensed 850,500
Stock-based compensation 219,929 520,404
Stock-based professional fees 55,525
Change in fair value of investment in joint ventures 581
Lease costs 3,245
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (155,221) 19,089
Accounts payable and accrued expenses (459,527) 938
NET CASH USED IN OPERATING ACTIVITIES (5,160,861) (3,315,681)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance common stock, net of offering costs 1,508,065
Proceeds from exercise of warrants 5,625,000 3,682,300
NET CASH PROVIDED BY FINANCING ACTIVITIES 7,133,065 3,682,300
NET INCREASE IN CASH AND CASH EQUIVALENTS 1,972,204 366,619
Effect of exchange rate changes on cash and cash equivalents 2,981 (4,134)
CASH AND CASH EQUIVALENTS - beginning of period 7,038,923 9,292,352
CASH AND CASH EQUIVALENTS - end of period 9,014,108 9,654,837
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Increase in deferred offering cost and additional paid-in capital 550,500
Increase in prepaid expenses and additional paid-in capital $ 333,150